GlassScriptPhysician profile
Jon F Suleskey
NPI 1841255585
$5,813.51
in general payments reported to CMS, 2019-2025
41 companies · $1,359 in 2025
The $1,359 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $666 · 2020: $204 · 2021: $718 · 2022: $612 · 2023: $1,279 · 2024: $976 · 2025: $1,359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,993 · Travel and Lodging: $452 · Education: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,992.56 |
| Travel and Lodging | $452.37 |
| Education | $168.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $867.41 | 2021-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $763.94 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $607.49 | 2019-2025 | Erleada |
| Sumitomo Pharma America, INC. | $438.35 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $391.36 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $303.44 | 2019-2025 | |
| Myovant Sciences INC. | $232.35 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $156.68 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Abbvie INC. | $141.72 | 2020-2024 | Botox, Lupron Depot |
| Boston Scientific Corporation | $138.01 | 2019-2025 | Spaceoar Vue System - 10ml |
| Accord Healthcare, INC. | $129.54 | 2023-2025 | |
| Coloplast Corp | $127.00 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $125.75 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $114.92 | 2019-2023 | Aveed, Xiaflex |
| Blue Earth Diagnostics | $101.56 | 2019-2024 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $83.44 | 2025 | Soltive, Uretero-Reno Videoscope |
| C. R. Bard, INC. & Subsidiaries | $83.38 | 2023-2025 | Bard Urinary Drainage Bag |
| Sunovion Pharmaceuticals INC. | $78.10 | 2021-2022 | |
| Amgen INC. | $68.63 | 2019-2023 | Xgeva |
| Allergan, INC. | $62.55 | 2020-2021 | |
| United Medical Systems (De), INC. | $62.34 | 2025 | |
| 180 Medical, INC. | $60.69 | 2022-2023 | Gentlecath Glide |
| Procept Biorobotics Corporation | $60.40 | 2024 | Aquabeam System |
| Valencia Technologies Corporation | $52.87 | 2024 | Ecoin Device Kit |
| Baxter Healthcare | $49.41 | 2021 | |
| Bard Access Systems, INC. | $42.00 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $41.87 | 2019-2021 | |
| Convatec INC. | $41.17 | 2023 | |
| Axonics, INC. | $40.67 | 2023 | Bulkamid, Axonics |
| Dendreon Pharmaceuticals LLC | $38.82 | 2020-2023 | Provenge |
| Cook Medical LLC | $38.81 | 2024 | Resonance, Cook |
| Ambu INC. | $30.91 | 2021-2023 | |
| Photocure INC | $30.66 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $30.34 | 2025 | |
| Travere Therapeutics, INC. | $29.24 | 2019-2021 | |
| Angiodynamics, INC. | $26.91 | 2024 | Nanoknife |
| Analogic Corporation | $26.55 | 2019 | |
| Laborie Medical Technologies Corp. | $24.33 | 2021 | |
| Myriad Genetic Laboratories, INC. | $23.91 | 2021 | |
| Rochester Medical Corporation | $23.65 | 2022 | |
| Endo USA, INC. | $22.34 | 2025 | Xiaflex, Aveed |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Suleskey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.